200 related articles for article (PubMed ID: 22863703)
1. Solid state characterizations and analysis of stability in azelnidipine polymorphs.
Li D; Wang M; Yang C; Wang J; Ren G
Chem Pharm Bull (Tokyo); 2012; 60(8):995-1002. PubMed ID: 22863703
[TBL] [Abstract][Full Text] [Related]
2. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic studies on the interaction of azelnidipine with bovine serum albumin.
Wang N; Ye L; Yan F; Xu R
Int J Pharm; 2008 Mar; 351(1-2):55-60. PubMed ID: 18029121
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the physical and thermodynamic stability of amorphous azelnidipine and its coamorphous phase with piperazine.
Du S; Li WS; Wu YR; Fu Y; Yang C; Wang J
RSC Adv; 2018 Sep; 8(57):32756-32764. PubMed ID: 35547669
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of a novel polymorph of indiplon, Form α.
Xu L; Wang J; Xiao B; Yang J; Liu Y; Huang R
Bioorg Med Chem Lett; 2012 Jan; 22(2):963-8. PubMed ID: 22209207
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
Tong HH; Shekunov BY; York P; Chow AH
Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
[TBL] [Abstract][Full Text] [Related]
8. Study of retinoic acid polymorphism.
Caviglioli G; Pani M; Gatti P; Parodi B; Cafaggi S; Bignardi G
J Pharm Sci; 2006 Oct; 95(10):2207-21. PubMed ID: 16883553
[TBL] [Abstract][Full Text] [Related]
9. Reevaluation of solubility of tolbutamide and polymorphic transformation from Form I to unknown crystal form.
Hasegawa G; Komasaka T; Bando R; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
Int J Pharm; 2009 Mar; 369(1-2):12-8. PubMed ID: 19026732
[TBL] [Abstract][Full Text] [Related]
10. [Enantiomeric separation of azelnidipine by high performance liquid chromatography with chiral stationary phase].
Zhang K; Xue N; Li L; Li F; Du Y
Se Pu; 2010 Feb; 28(2):215-7. PubMed ID: 20556964
[TBL] [Abstract][Full Text] [Related]
11. Solid-state characterization of chlordiazepoxide polymorphs.
Singh D; Marshall PV; Shields L; York P
J Pharm Sci; 1998 May; 87(5):655-62. PubMed ID: 9572919
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of tedisamil dihydrochloride.
Henck JO; Finner E; Burger A
J Pharm Sci; 2000 Sep; 89(9):1151-9. PubMed ID: 10944380
[TBL] [Abstract][Full Text] [Related]
13. Characterization of polymorphic ampicillin forms.
Baraldi C; Tinti A; Ottani S; Gamberini MC
J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
[TBL] [Abstract][Full Text] [Related]
14. Solid state characterization of dehydroepiandrosterone.
Chang LC; Caira MR; Guillory JK
J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
[TBL] [Abstract][Full Text] [Related]
15. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
Niederwanger V; Gozzo F; Griesser UJ
J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective determination of azelnidipine in human plasma using liquid chromatography-tandem mass spectrometry.
Kawabata K; Samata N; Urasaki Y; Fukazawa I; Uchida N; Uchida E; Yasuhara H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):389-97. PubMed ID: 17350354
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic Stability Analysis of Tolbutamide Polymorphs and Solubility in Organic Solvents.
Svärd M; Valavi M; Khamar D; Kuhs M; Rasmuson ÅC
J Pharm Sci; 2016 Jun; 105(6):1901-1906. PubMed ID: 27238487
[TBL] [Abstract][Full Text] [Related]
18. Four new polymorphic forms of suplatast tosilate.
Nagai K; Ushio T; Miura H; Nakamura T; Moribe K; Yamamoto K
Int J Pharm; 2014 Jan; 460(1-2):83-91. PubMed ID: 24211359
[TBL] [Abstract][Full Text] [Related]
19. Neotame anhydrate polymorphs. II: Quantitation and relative physical stability.
Dong Z; Munson EJ; Schroeder SA; Prakash I; Grant DJ
Pharm Res; 2002 Sep; 19(9):1259-64. PubMed ID: 12403060
[TBL] [Abstract][Full Text] [Related]
20. Solid state characterization of E2101, a novel antispastic drug.
Kushida I; Ashizawa K
J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
